Regulated production of mature insulin by non-beta-cells

Human Gene Therapy
L GrosF Bosch

Abstract

Rat hepatoma cells were engineered to express, in a regulated manner, mature human insulin as an approach to the development of artificial beta-cells for insulin-dependent diabetes mellitus (IDDM) gene therapy. A chimeric gene obtained by linking a 2.4-kb fragment of the P-enolpyruvate carboxykinase (PEPCK) gene promoter to a human proinsulin gene (PEPCK/Insm), containing genetically engineered furin endoprotease cleavage sites, was stably transfected into FTO-2B rat hepatoma cells. The FTOInsm cells expressed high levels of insulin mRNA and protein after Northern blot or immunocytochemical analysis. High-performance liquid chromatography (HPLC) fractionation of culture medium and cell extracts revealed that about 90% of the proinsulin was processed to mature insulin. Insulin secretion was very fast, and 15 min after induction with dibutyryl cyclic AMP (Bt2cAMP) plus dexamethasone significant amounts of the hormone were released. Moreover, during the first hour, the rise in insulin concentration in the medium was 10-fold that detected in nontreated FTOInsm cells. Insulin produced by FTOInsm cells was biologically active because it blocked endogenous PEPCK gene expression and induced glucose uptake and lactate production. Thus, ...Continue Reading

References

Feb 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·W L ChickK C Kitchen
Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S P SmeekensP Gardner
Aug 1, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·N B RudermanM Brownlee
Jan 1, 1987·Progress in Nucleic Acid Research and Molecular Biology·A Wynshaw-BorisR W Hanson
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S EfratS Baekkeskov
Jan 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·P Gruss, G Khoury
Jul 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·R F SanterreC P Wilson
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·W H LamersH M Meisner
Jan 1, 1995·Annual Review of Biochemistry·C B Newgard, J D McGarry
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·T M KolodkaS L Woo
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·L MontoliuG Schütz
Apr 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A ValeraF Bosch
Oct 1, 1993·Journal of Biomedical Materials Research·H Uludag, M V Sefton
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Aug 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·I T Tai, A M Sun
Jun 1, 1993·Diabetes·J R WilliamsonR G Tilton
May 9, 1996·The New England Journal of Medicine·A M Jacobson
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·E RiuA Valera
Aug 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·T FerreA Valera

❮ Previous
Next ❯

Citations

Mar 30, 2000·The Journal of Gene Medicine·O L KonY C Long
Feb 13, 2001·Experimental Hematology·I Guest, J Uetrecht
Oct 30, 1998·Molecular Medicine Today·A W Varley, R S Munford
Dec 2, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jaeseok HanHee-Sook Jun
Feb 15, 2001·Human Gene Therapy·S C BarryW R Osborne
Oct 28, 2003·Human Gene Therapy·Darin E OlsonPeter M Thulé
Aug 14, 1999·Human Gene Therapy·F Paillard
May 26, 1999·Human Gene Therapy·L GrosF Bosch
Jul 23, 1999·Annals of the New York Academy of Sciences·C J WeberJ Kapp
Feb 1, 2005·Journal of Autoimmune Diseases·Muhammad T TabiinBernard E Tuch
Dec 1, 2012·World Journal of Gastroenterology : WJG·Jaeseok HanHee-Sook Jun
May 26, 2004·Transplant Immunology·Ammon B Peck, Vijayakumar Ramiya
Jun 5, 2003·Expert Opinion on Biological Therapy·Takashi Yamaoka
Apr 26, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·R ChenS L Woo
Mar 1, 2000·Gene Therapy·P M ThuléL S Phillips
Nov 18, 2000·Gene Therapy·P M Thulé, J M Liu
Sep 27, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Philipp C NettTausif Alam
Jun 25, 2005·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Marty H PorterPeter M Thulé
Apr 2, 2002·World Journal of Gastroenterology : WJG·Xin-Yu QinZe-Guang Han

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.